Canadian medical cannabis firm targeted in class-action suit

420Patients.com is accepting qualified medical marijuana patients and caregivers to join our network. We value every registered member and we hope to serve you in Arizona. This article brought to you by 420 community friends mmjbusinessdaily.com

Canadian medical marijuana producer Organigram, having already replaced its CEO, now is the subject of a proposed class-action lawsuit involving pesticide-contaminated cannabis.

A court must  certify the proposed lawsuit before it can proceed.

A Halifax-based law firm alleged in its Friday filing that the lead plaintiff consumed Organigram’s MMJ products for almost a year before learning the cannabis could be contaminated with potentially toxic pesticides, the Montreal Gazette reported.

The firm also said in its proposed lawsuit that upwards of 2,000 Canadians may have purchased medical marijuana products containing either myclobutanil or bifenazate, pesticides that are not approved for

Canadian medical cannabis firm targeted in class-action suit is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Leave a Reply

Skip to toolbar